Literature DB >> 14520629

Association of ENOS polymorphism with basal peritoneal membrane function in uremic patients.

Teresa Yuk-Hwa Wong1, Cheuk-Chun Szeto, Carol Yi-Ki Szeto, Ka-Bik Lai, Kai-Ming Chow, Philip Kam-Tao Li.   

Abstract

BACKGROUND: Basal peritoneal permeability has a major impact on the outcome of peritoneal dialysis (PD) patients, but the determinant of this is unknown. Early evidence suggests that peritoneal permeability is affected by nitric oxide (NO) activity. Recently, a gene polymorphism of the endothelial NO synthase (ENOS) gene was identified that is associated with circulating nitrate levels.
METHODS: We performed a cross-sectional study to examine the relationship between ENOS4(a/b) gene polymorphism and basal peritoneal function in 86 Chinese incident PD patients. ENOS genotypes for variable number tandem repeats in intron 4 (a/b) were identified by polymerase chain reaction. Patients were classified into 2 groups according to results of a basal peritoneal equilibration test (PET) performed within 2 months of dialysis therapy: group A consisted of patients with low (L)/L average (LA) PET results, and group B consisted of those with H and HA PET results.
RESULTS: Group A (L/LA) had a significantly greater prevalence of ENOS aa/ab genotype than group B (H/HA; 30% versus 12%; P < 0.05). Frequencies of the ENOS a allele also were greater in group A (L/LA) than group B (H/HA) (16% versus 6%; P = 0.03). ENOS genotype remained an independent predictor for peritoneal transport after adjustment for sex, body weight, and prevalence of diabetes by multivariate analysis (adjusted odds ratio, 3.3; confidence interval, 1.1 to 3.7; P = 0.03). Subjects with the aa/ab genotype had significantly lower mass transfer area coefficients (7.35 +/- 3.4 versus 9.48 +/- 5.21 mL/min; P = 0.023) and dialysate-plasma creatinine ratios at 4 hours (0.55 +/- 0.13 versus 0.62 +/- 0.14; P = 0.048) than those with the bb genotype.
CONCLUSION: ENOS4(a/b) gene polymorphism is associated with basal peritoneal permeability in uremic Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520629     DOI: 10.1016/s0272-6386(03)00855-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  6 in total

Review 1.  Genetic Polymorphisms and Peritoneal Membrane Function.

Authors:  Imad Siddique; K Scott Brimble; Louise Walkin; Angela Summers; Paul Brenchley; Sarah Herrick; Peter J Margetts
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

Review 2.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

3.  Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients.

Authors:  Lanbo Teng; Ming Chang; Shuxin Liu; Min Niu; Yungang Zhang; Xiangfei Liu; Xiaoxia Yu
Journal:  Int Urol Nephrol       Date:  2014-07-08       Impact factor: 2.370

Review 4.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

Review 5.  The Peritoneal Membrane-A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis.

Authors:  Margarita Kunin; Pazit Beckerman
Journal:  Membranes (Basel)       Date:  2022-03-11

Review 6.  Opportunities and Challenges for Genetic Studies of End-Stage Renal Disease in Canada.

Authors:  Vinusha Kalatharan; Mathieu Lemaire; Matthew B Lanktree
Journal:  Can J Kidney Health Dis       Date:  2018-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.